Search Results 1691-1700 of 16891 for Humira
TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic activity of ...
Dr. Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. 'Virtual ...
About this study. This clinical trial evaluates whether offering human papillomavirus (HPV) self-collection for cervical cancer screening at Mayo Clinic ...
Sharon Conoley had been feeling anxious since she received a diagnosis of a large kidney stone in a solitary kidney. But once she made the[...].
ROCHESTER, Minn. — Mayo Clinic has announced a gift of $200 million from Jay Alix, noted philanthropist of Birmingham, Mich. and founder of the firm,[...].
ROCHESTER, Minn. — Mayo Clinic researchers have uncovered how aging "zombie cells" trigger harmful inflammation that accelerates a severe and increasingly ...
placebo in patients with hereditary hemorrhagic telangiectasia (HHT) with moderate-to-severe epistaxis who require parenteral iron infusions or blood ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Severe weather across many parts of the country has caused a lot of problems, but one effect you may not have heard about is on[...].
Landmark Mayo Clinic study finds stenting reduces stroke risk in people with carotid artery narrowing featured · Mayo Clinic physicians map patients' brain waves ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.